Efficacy and Safety of Fingolimod in an Unselected Patient Population

BACKGROUND: Fingolimod is a first in class oral compound approved for the treatment of relapsing-remitting multiple sclerosis (RR-MS). The aim of this study was to evaluate clinical and neuroradiological responses to fingolimod as well as the safety and tolerability in RR-MS patients in clinical pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasenack, Maria, Rychen, Jonathan, Andelova, Michaela, Naegelin, Yvonne, Stippich, Christoph, Kappos, Ludwig, Lindberg, Raija L. P., Sprenger, Till, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703383/
https://www.ncbi.nlm.nih.gov/pubmed/26734938
http://dx.doi.org/10.1371/journal.pone.0146190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703383/
https://www.ncbi.nlm.nih.gov/pubmed/26734938
http://dx.doi.org/10.1371/journal.pone.0146190

Ejemplares similares